Search Results
Long-term effectiveness of levodopa-carbidopa intestinal gel in Parkinson's disease
The ELEGANCE study: levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease
Optimizing Levodopa-Carbidopa Intestinal Gel Dosing in Parkinson's
Levodopa-carbidopa intestinal gel in multiple system atrophy
Extending the efficacy of levodopa in patients with Parkinson’s disease
Levodopa dose adjustment versus adjunctive therapy in Parkinson’s disease
Final results of DUOGLOBE: real-world evidence for LGIC in advanced Parkinson’s disease
Long term effects of treating levodopa-induced dyskinesia with sub-anesthetic ketamine
Rajesh Pahwa, MD: Underutilization of Levodopa-Carbidopa Intestinal Gel
The impact of LCIG on dyskinesia duration & severity in PD
Duodopa and Vyalev: Pump Therapies for Parkinson’s
Rajesh Pahwa, MD: Understanding Levodopa-Carbidopa Treatment Impact
